Sangamo Therapeutics (SGMOQ) Other Non-Current Assets (2010 - 2025)

Sangamo Therapeutics has reported Other Non-Current Assets for 16 years, with the latest figure at $871000.0 in Q4 2025.

• On a quarterly basis, Other Non-Current Assets fell 41.93% year-over-year to $871000.0 in Q4 2025; TTM through Dec 2025 was $871000.0, a 41.93% decrease from a year earlier, with the FY2025 full-year figure at $871000.0, down 41.93% from the prior year.
• Other Non-Current Assets was $871000.0 for Q4 2025 at Sangamo Therapeutics, roughly flat from $871000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $17.4 million in Q2 2023, with the low at $871000.0 in Q3 2025.
• Average Other Non-Current Assets over 5 years is $10.2 million, with a median of $14.9 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2023: Other Non-Current Assets jumped 48.86% in 2021, then slumped 91.19% in 2023.
• Over 5 years, Other Non-Current Assets stood at $15.3 million in 2021, then increased by 11.12% to $17.0 million in 2022, then plunged by 91.19% to $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then plunged by 41.93% to $871000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $871000.0 (Q4 2025), $871000.0 (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.